These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 3537795)

  • 1. Subcutaneous-insulin-resistance syndrome.
    N Engl J Med; 1987 Jan; 316(1):49-51. PubMed ID: 3537795
    [No Abstract]   [Full Text] [Related]  

  • 2. In search of the subcutaneous-insulin-resistance syndrome.
    Schade DS; Duckworth WC
    N Engl J Med; 1986 Jul; 315(3):147-53. PubMed ID: 3523242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of diabetes through a subcutaneous peritoneal access device (SPAD) in patients with resistance to subcutaneously injected insulin.
    Dandona P; Fonseca V; Fernando O; Menon RK; Weerakoon J; Kurtz A; Stephen R
    Diabetes Res; 1987 May; 5(1):47-9. PubMed ID: 3304785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin allergy and insulin resistance.
    Goldfine AB; Kahn CR
    Curr Ther Endocrinol Metab; 1994; 5():461-4. PubMed ID: 7704774
    [No Abstract]   [Full Text] [Related]  

  • 5. Insulin binding in children with diabetes mellitus.
    Murthy DY; Guthrie RA; Womack WN; Jackson RL
    Pediatrics; 1969 Apr; 43(4):558-66. PubMed ID: 5813380
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in tissue insulin sensitivity in previously "brittle" diabetics.
    Taylor R; Hetherington CS; Gill GV; Alberti KG
    Horm Metab Res; 1986 Jul; 18(7):493. PubMed ID: 3527930
    [No Abstract]   [Full Text] [Related]  

  • 7. Insulin action in insulin-dependent diabetes mellitus (type I): measurement during constant and changing insulin concentrations.
    Doeden B; Rizza R
    J Lab Clin Med; 1988 Jul; 112(1):28-35. PubMed ID: 3292681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of atherosclerosis in diabetes mellitus. The role of insulin resistance and hyperinsulinemia].
    Kostiuk Ep; Zubkova ST
    Fiziol Zh (1978); 1993; 39(5-6):93-8. PubMed ID: 8045324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes resistant to subcutaneous insulin: effect of aprotinin.
    N Engl J Med; 1981 Dec; 305(23):1413-4. PubMed ID: 6170889
    [No Abstract]   [Full Text] [Related]  

  • 10. Patient tips from industry. Injection site selection.
    Diabetes Educ; 2004; 30(2):180-2. PubMed ID: 15095509
    [No Abstract]   [Full Text] [Related]  

  • 11. Dramatic improvement of subcutaneous insulin resistance with nafamostat ointment treatment.
    Kawashima S; Kaneto H; Sakamoto K; Honsho I; Yasuda T; Kuroda A; Shiraiwa T; Kasami R; Matsuoka TA; Yamasaki Y; Matsuhisa M
    Diabetes Care; 2008 Mar; 31(3):e11. PubMed ID: 18308674
    [No Abstract]   [Full Text] [Related]  

  • 12. [Status of lipid metabolism in diabetes mellitus type 1 depending upon the degree of compensation of carbohydrate metabolism].
    Balabolkin MI; Antonova TI; Allamiiarov BU
    Sov Med; 1988; (4):110-2. PubMed ID: 3043707
    [No Abstract]   [Full Text] [Related]  

  • 13. Continuous subcutaneous insulin infusion is better than multiple daily insulin injections in reducing glucose variability only in type 1 diabetes with good metabolic control.
    Lepore G; Corsi A; Dodesini AR; Nosari I; Trevisan R
    Diabetes Care; 2010 Jun; 33(6):e81. PubMed ID: 20508226
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device ("Infusaid").
    Campbell IW; Kritz H; Najemnik C; Hagmueller G; Irsigler K
    Diabetes Res; 1984 Jul; 1(2):83-8. PubMed ID: 6442226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conventional and human insulin: complications of insulin therapy in children.
    MacDonald MJ
    Prim Care; 1983 Dec; 10(4):691-706. PubMed ID: 6371864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral and inhaled insulin: is it a breakthrough and what does it amount to?].
    Harsch IA; Fuchs FS; Hahn EG; Ficker JH
    Dtsch Med Wochenschr; 2001 Mar; 126(13):374-7. PubMed ID: 11332234
    [No Abstract]   [Full Text] [Related]  

  • 17. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 18. Subcutaneous insulin resistance syndrome. Effects of long-term aprotinin therapy.
    Guillausseau PJ; Guillausseau C; Boucheteil P; Lubetzki J
    Diabetes Res; 1986 Sep; 3(7):387-9. PubMed ID: 2430751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous microdialysis before and after an oral glucose tolerance test: a method to determine insulin resistance in the subcutaneous adipose tissue in diabetes mellitus.
    Rajamand N; Ungerstedt U; Brismar K
    Diabetes Obes Metab; 2005 Sep; 7(5):525-35. PubMed ID: 16050945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to insulin.
    Muşeţeanu P; Oprescu S
    Endocrinologie; 1988; 26(3):221-6. PubMed ID: 3062758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.